Top compounds associated with response to TSPY1


Feature Type Standardized
Nominal ANOVA
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.09 0.01
mRNA Bosutinib CTRPv2 pan-cancer AAC -0.084 0.01
mRNA methylstat CTRPv2 pan-cancer AAC 0.1 0.01
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.01
mRNA austocystin d CTRPv2 pan-cancer AAC -0.085 0.02
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC 0.12 0.02
mRNA neratinib CTRPv2 pan-cancer AAC -0.078 0.02
mRNA SMER-3 CTRPv2 pan-cancer AAC -0.083 0.03
mRNA canertinib CTRPv2 pan-cancer AAC -0.078 0.03
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.03
Download CSV